Maloon Powers Pitre Higgins & Dennehy’s Pfizer PFE Stock Holding History

Maloon Powers Pitre Higgins & Dennehy’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Buy	+9,436	New	+$247K	0.08%	134

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Maloon Powers Pitre Higgins & Dennehy's PFE Position: Q2 2026 in Review

Maloon Powers Pitre Higgins & Dennehy opened a new position in Pfizer (PFE) in Q2 2026: 9,436 shares worth $227K. The stake represents 0.08% of the portfolio and ranks #134 among its holdings.

2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Maloon Powers Pitre Higgins & Dennehy held 9,436 shares of Pfizer worth $227K as of Q2 2026.
Pfizer was a new Maloon Powers Pitre Higgins & Dennehy position in Q2 2026.
Pfizer made up 0.08% of Maloon Powers Pitre Higgins & Dennehy's portfolio in Q2 2026, its #134 holding.
2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Maloon Powers Pitre Higgins & Dennehy's 13F filing for Q2 2026, filed 14 Aug 2026.